CannTrust (TSE:TRST) Downgraded to “Sell” at Eight Capital

CannTrust (TSE:TRST) was downgraded by equities research analysts at Eight Capital from a “neutral” rating to a “sell” rating in a research report issued to clients and investors on Friday, BayStreet.CA reports. They currently have a C$4.00 target price on the stock, down from their prior target price of C$6.00. Eight Capital’s target price would indicate a potential upside of 14.29% from the company’s current price.

Several other research analysts have also issued reports on the stock. Cormark raised their target price on shares of Parex Resources from C$32.50 to C$35.00 in a research note on Tuesday. Canaccord Genuity reaffirmed a “buy” rating on shares of Dart Group in a research note on Thursday. Bank of America reaffirmed a “buy” rating and issued a C$11.00 target price on shares of CannTrust in a research note on Friday, May 24th. Finally, Jefferies Financial Group raised their target price on shares of Monster Beverage from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Friday, May 3rd.

TSE:TRST traded down C$0.54 during mid-day trading on Friday, reaching C$3.50. 3,606,426 shares of the company were exchanged, compared to its average volume of 2,017,339. CannTrust has a 12 month low of C$3.48 and a 12 month high of C$15.50. The firm’s fifty day moving average is C$6.73. The company has a debt-to-equity ratio of 8.20, a quick ratio of 1.90 and a current ratio of 5.64. The stock has a market capitalization of $667.80 million and a PE ratio of -29.01.

CannTrust Company Profile

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Featured Story: Special Dividends

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply